Loss of PPM1B thus leads to sustained MYPT1 phosphorylation, reduced MP activity, and enhanced PRMT5 activation—a cascade that promotes tumorigenesis via epigenetic silencing of tumor suppressor genes. This evidence concerns the gene PRMT5 and neoplasm.